IQVIA Holdings (BSP:I1QV34) Institutional Ownership : 0.00% (As of May. 18, 2024)

View and export this data going back to 2020. Start your Free Trial

What is IQVIA Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IQVIA Holdings's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IQVIA Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IQVIA Holdings's Float Percentage Of Total Shares Outstanding is 0.00%.

IQVIA Holdings Institutional Ownership Historical Data

The historical data trend for IQVIA Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Institutional Ownership Chart

IQVIA Holdings Historical Data

The historical data trend for IQVIA Holdings can be seen below:

	2022-07-31
Institutional Ownership	0.01

IQVIA Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

IQVIA Holdings (BSP:I1QV34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (BSP:I1QV34) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

IQV:USA IQV:Mexico QTS:Germany QTS:Germany

Address

2400 Ellis Road, Durham, NC, USA, 27703

Website

https://www.iqvia.com

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (BSP:I1QV34) Headlines

No Headlines